Miaoshou Doctor Enhances Patient Adherence Through Efficient Post-Diagnosis Care Management
In recent years, a series of national policies encouraging the expansion of long-term post-consultation service chains and the development of internet hospitals have promoted the growth of online healthcare companies such as Miaoshou Hospital in the field of post-consultation management. VCBeat Think Tank released the "White Paper on Online Post-Consultation Disease Management in China 2018," which comprehensively analyzed the impact of post-consultation disease management on the rehabilitation of chronic disease patients and the future development potential of chronic disease management in China through research on online post-consultation disease management services in China.
According to white paper statistics, the number of chronic disease patients in China reached 370 million in 2017, including 290 million with cardiovascular diseases and 114 million with diabetes. The disease burden attributable to chronic conditions accounts for nearly 70% of the total disease burden. Due to a lack of professional guidance, some patients experience diminished self-management capabilities after discharge, leading to issues such as unauthorized medication discontinuation and failure to attend timely follow-up visits. Post-diagnosis disease management maintains one-on-one communication with patients through continuous care, promptly adjusts treatment and medication regimens, sustains high post-discharge follow-up rates, and enhances patient satisfaction with healthcare providers. This ensures the continuity of treatment plans and improves overall therapeutic outcomes.
(Figure: Content of the White Paper)
Miaoshou Doctor leverages its online internet hospital to provide patients with a comprehensive, end-to-end service encompassing remote follow-up consultations, e-prescriptions, and medication purchasing. This eliminates the need for patients to make repeated trips to physical hospitals. The platform establishes more complete personal electronic medical records that include “full consultation histories, medical imaging, disease progression tracking, and medication usage,” thereby assisting physicians in delivering continuous post-consultation disease management.
To ensure the safety and timeliness of patient medication, Miaoshou Doctor leverages blockchain technology to secure the pharmaceutical supply chain, while employing professional warehousing and transportation solutions, including cold-chain logistics, to guarantee drug quality. By collaborating with over 100 pharmacies across nearly 40 cities in China, it ensures operational efficiency in pharmaceutical distribution and broad drug availability. During service delivery, Miaoshou Doctor monitors patients’ medication adherence, providing timely reminders to prevent interruptions in treatment. Furthermore, it addresses common concerns such as drug administration instructions, dietary restrictions, and changes in health indicators through ongoing communication, thereby significantly improving patient compliance.
Miaoshou Doctor has established partnerships with over 1,000 renowned domestic and international pharmaceutical companies. Recently, it has further collaborated with specialist physician groups and medical institutions to optimize post-diagnosis management services for single diseases. While providing patients with services closely aligned with their prescriptions, these single-disease post-diagnosis management services also enhance medication adherence and improve therapeutic outcomes.